Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS

Autor: Ding XY, Hong CJ, Liu Y, Gu ZL, Xing KL, Zhu AJ, Chen WL, Shi LS, Zhang XN, Zhang Q

Publikováno v: International Journal of Nanomedicine, Vol 2012, Iss default, Pp 1723-1735 (2012)

Xin-Yuan Ding1, Cheng-Jiao Hong2, Yang Liu1, Zong-Lin Gu1, Kong-Lang Xing1, Ai-Jun Zhu1, Wei-Liang Chen1, Lin-Seng Shi1, Xue-Nong Zhang1, Qiang Zhang31Department of Pharmaceutics, College of Pharmaceutical science, Soochow University, Suzhou, 2Jiang

Externí odkaz: https://doaj.org/article/0484a9e4abb74165b9eb2711676c39c3

Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.

Autor: Lin WP; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Xing KL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Department of Pancreatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China., Fu JC; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, China., Ling YH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, China., Li SH; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Yu WS; Department of General Surgery, Dongguan People's Hospital, Southern Medical University, Dongguan City, China., Zhang YF; Department of Hepatic Surgery, Fudan University, Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Zhong C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Wang JH; Department of Abdominal Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China., Chen ZY; Department of Gastroenterology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Human Normal University, Changsha, China., Lu LH; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Wei W; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Guo RP; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

Publikováno v: JAMA network open [JAMA Netw Open] 2021 Sep 01; Vol. 4 (9), pp. e2125055. Date of Electronic Publication: 2021 Sep 01.

A Novel Prognostic Nomogram for Patients With Recurrence of Intrahepatic Cholangiocarcinoma After Initial Surgery.

Autor: Xing KL; Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Lu LH; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, Guangzhou, China., Huang X; Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., He CB; Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Song YD; Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Guo RP; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, Guangzhou, China., Li SP; Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

Publikováno v: Frontiers in oncology [Front Oncol] 2020 Apr 02; Vol. 10, pp. 434. Date of Electronic Publication: 2020 Apr 02 (Print Publication: 2020).

Prognostic and predictive value of serum carcinoembryonic antigen levels in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutations and receiving tyrosine kinase inhibitors.

Autor: Zhao XM; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Zhao J; Department of Medical Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Shanghai 200433, China., Xing KL; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Sun S; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Luo ZG; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Wang HJ; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Wang JL; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Chang JH; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China., Wu XH; Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

Publikováno v: Oncotarget [Oncotarget] 2017 Aug 10; Vol. 8 (41), pp. 70865-70873. Date of Electronic Publication: 2017 Aug 10 (Print Publication: 2017).

Unlabeled multi tumor marker detection system based on bioinitiated light addressable potentiometric sensor.

Autor: Jia YF; College of Information Science Technology, Nankai University, 300071, China. jiayunfang@yahoo.com.cn, Gao CY, He J, Feng DF, Xing KL, Wu M, Liu Y, Cai WS, Feng XZ

Publikováno v: The Analyst [Analyst] 2012 Aug 21; Vol. 137 (16), pp. 3806-13. Date of Electronic Publication: 2012 Jul 05.